Rapid identification of Candida species in blood cultures by a clinically useful PCR method

Journal of Clinical Microbiology

Volumn 35, Issue 6, 1997, Pages 1454-1459

  Shin, Jong Hee ^a   Nolte, Frederick S ^b   Morrison, Christine J ^c,d  

^a Chonnam National University Medical School   (South Korea)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CULTURE; CANDIDIASIS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FUNGUS CULTURE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI;

EID: 0344093869     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.6.1454-1459.1997     Document Type: Article

References (24)

1. Beck-Sagué, C., and W. R. Jarvis. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980-1990. National Nosocomial Infections Surveillance System. J. Infect. Dis. 167:1247-1251.
2. Buchman, T. G., M. Rossier, W. G. Merz, and P. Charache. 1990. Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of C. albicans by in vitro amplification of a fungus-specific gene. Surgery 108:338-347.
3. Burgener-Kairuz, P., J.-P. Zuber, P. Jaunin, T. G. Buchman, J. Billie, and M. Rossier. 1994. Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-α-demethylase (L1A1) gene fragment. J. Clin. Microbiol. 32:1902-1907.
4. Dooley, D. P., M. L. Beckius, and B. S. Jeffrey. 1994. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card. J. Clin. Microbiol. 32:2889-2892.
5. Fraser, V. J., M. Jones, J. Dunkel, S. Storfer, G. Medoff, and W. C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414-421.
6. Fujita, S.-I., B. A. Lasker, T. J. Lott, E. Reiss, and C. J. Morrison. 1995. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J. Clin. Microbiol. 33:962-967.
7. Holmes, A. R., Y. C. Lee, R. D. Cannon, H. F. Jenkinson, and M. G. Shepard. 1992. Yeast-specific DNA probes and their application for the detection of Candida albicans. J. Med. Microbiol. 37:346-351.
8. Hopfer, R. L., P. Walden, S. Setterquist, and W. E. Highsmith. 1993. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J. Med. Vet. Mycol. 31:65-75.
9. Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
10. Jones, J. M. 1990. Laboratory diagnosis of invasive candidiasis. Clin. Microbiol. Rev. 3:32-45.
11. Kan, V. L. 1993. Polymerase chain reaction for the diagnosis of candidemia. J. Infect. Dis. 168:799-783.
12. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature (London) 339:237-238.
13. Matthews, R. C. 1993. Early diagnosis of systemic Candida infection. J. Antimicrob. Chemother. 31:809-812.
14. Miyakawa, Y., T. Mabuchi, and Y. Fukazawa. 1993. New method for detection of Candida albicans in human blood by polymerase chain reaction. J. Clin. Microbiol. 31:3344-3347.
15. Nguyen, M. H., J. E. Peacock, Jr., A. J. Morris, D. C. Tanner, M. L. Nguyen, D. R. Snydman, M. M. Wagener, M. G. Rinaldi, and V. L. Yu. 1996. The changing face of candidemia: emergence of non-Candida species and antifungal resistance. Am. J. Med. 100:617-623.
16. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
17. Panaccio, M., and A. Lew. 1991. PCR based diagnosis in the presence of 8% (v/v) blood. Nucleic Acids Res. 19:1151.
18. Pfaller, M. A. 1995. Epidemiology of fungal infections. J. Hosp. Infect. 30(Suppl):329-338.
19. Price, M. F., M. T. LaRocco, and L. O. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38:1422-1424.
20. Reiss, E., and C. J. Morrison. 1993. Nonculture methods for diagnosis of disseminated candidiasis. Clin. Microbiol. Rev. 6:311-323.
21. Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb for the NIAID Mycoses Study Group and the Candidemia Study Group. 1994. Antifungal susceptibility testing of isolates from a randomised, multicenter trial of fluconazole versus amphotericin B for the treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 38:1422-1424.
22. van Deventer, A. J. M., W. H. F. Goessens, A. van Belkum, H. J. A. van Vliet, E. W. M. van Etten, and H. A. Verbrugh. 1995. Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J. Clin. Microbiol. 33:625-628.
23. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.
24. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.